© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 0794T refers to a patient-specific, assistive, rules-based algorithm designed to rank pharmaco-oncologic treatment options tailored to the individual patient's tumor-specific cancer marker information. This information is derived from prior molecular pathology, immunohistochemical, or other pathology results that have been previously interpreted and reported separately. The algorithm is instrumental in providing a systematic approach to evaluating available treatment options, ensuring that the ranking is based solely on FDA-approved drugs. The process begins with the physician or qualified healthcare professional compiling all relevant clinical data specific to the patient's tumor, which includes previously interpreted results from molecular, laboratory, and pathology tests. Importantly, any raw data from genomic sequencing is excluded from this analysis. The output of the algorithm is a comprehensive report that ranks potential therapies, enabling the physician to make informed decisions regarding subsequent treatment plans aimed at effectively targeting the patient's specific cancer.
© Copyright 2025 Coding Ahead. All rights reserved.
The use of CPT® Code 0794T is indicated for patients who require a tailored approach to their cancer treatment based on specific tumor characteristics. The following conditions warrant the application of this algorithm:
The procedure associated with CPT® Code 0794T involves several key steps that ensure the effective ranking of treatment options based on the patient's unique cancer characteristics. Each step is crucial for the accurate application of the algorithm:
After the application of CPT® Code 0794T and the generation of the treatment ranking report, the physician will engage in a discussion with the patient regarding the recommended treatment options. This may involve explaining the rationale behind the selected therapies and addressing any questions or concerns the patient may have. The physician will then proceed to implement the chosen treatment plan, monitoring the patient's response to therapy and making adjustments as necessary based on ongoing evaluations and clinical outcomes. Continuous follow-up is essential to ensure that the treatment remains effective and aligned with the patient's evolving clinical status.
Short Descr | PT SPEC ALG RX-ONC TX OPTION | Medium Descr | PT SPEC ALG RANKING PHARMACOONCOLOGIC TX OPTIONS | Long Descr | Patient-specific, assistive, rules-based algorithm for ranking pharmaco-oncologic treatment options based on the patient's tumor-specific cancer marker information obtained from prior molecular pathology, immunohistochemical, or other pathology results which have been previously interpreted and reported separately | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 3 - Technical Component Only Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 1 - Statutory payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Not Discounted when Multiple | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
Date
|
Action
|
Notes
|
---|---|---|
2024-01-01 | Added | First appearance in code book. |
2023-07-01 | Added | Code added. |
Get instant expert-level medical coding assistance.